1-(2-bromo-5-methylthiazol-4-yl)ethan-1-one | 1280703-71-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 1-(2-bromo-5-methylthiazol-4-yl)ethan-1-one
• 英文别名: 1-(2-Bromo-5-methyl-1,3-thiazol-4-yl)ethan-1-one；1-(2-bromo-5-methyl-1,3-thiazol-4-yl)ethanone
• CAS: 1280703-71-0
• 化学式: C₆H₆BrNOS
• 分子量: 220.09
• InChiKey: OBLRYUORPVWFAI-UHFFFAOYSA-N

物化性质

• 沸点：
  279.3±20.0 °C(Predicted)
• 密度：
  1.616±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  58.2
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  1-哌啶丙醇 、 1-(2-bromo-5-methylthiazol-4-yl)ethan-1-one 在 sodium hydride 作用下， 以 四氢呋喃 、 mineral oil 为溶剂， 反应 7.0h， 生成 1-(5-Methyl-2-(3-(piperidin-1-yl)propoxy)thiazol-4-yl)ethanone
  参考文献：
  名称：

  作为组胺H 3受体拮抗剂的唑衍生物，第I部分：噻唑-2-基醚

  摘要：

  大多数人类组胺H 3受体（h H 3 R）拮抗剂遵循一般的结构蓝图，其包含通过间隔子连接至取代的核心元素的基本部分。在该研究中，通过一些在纳摩尔浓度范围内显示出h H 3 R结合亲和力的醚衍生物证明了噻唑-2-基醚部分在核心区域的接受。多种结构基序用作取代基，以增强体外h H 3 R的结合亲和力。

  DOI：

  10.1016/j.bmcl.2010.07.098
• 作为产物：
  描述：

  亚硝酸特丁酯 、 1-(2-氨基-5-甲基-1,3-噻唑-4-基)乙酮 1HCL 在 copper(ll) bromide 作用下， 以 乙腈 为溶剂， 生成 1-(2-bromo-5-methylthiazol-4-yl)ethan-1-one
  参考文献：
  名称：

  作为组胺H 3受体拮抗剂的唑衍生物，第I部分：噻唑-2-基醚

  摘要：

  大多数人类组胺H 3受体（h H 3 R）拮抗剂遵循一般的结构蓝图，其包含通过间隔子连接至取代的核心元素的基本部分。在该研究中，通过一些在纳摩尔浓度范围内显示出h H 3 R结合亲和力的醚衍生物证明了噻唑-2-基醚部分在核心区域的接受。多种结构基序用作取代基，以增强体外h H 3 R的结合亲和力。

  DOI：

  10.1016/j.bmcl.2010.07.098

文献信息

• 4-SUBSTITUTED PYRIDIN-3-YL-CARBOXAMIDE COMPOUNDS AND METHODS OF USE
  申请人：Wang Xiaojing

  公开号：US20110059961A1

  公开（公告）日：2011-03-10

  The invention relates to compounds of formula (I) which are useful as kinase inhibitors, more specifically useful as PIM kinase inhibitors, thus useful as cancer therapeutics. The invention also relates to compositions, more specifically pharmaceutical compositions comprising these compounds and methods of using the same, either alone or in combination, to treat various forms of cancer and hyperproliferative disorders, as well as methods of using the compounds for in vitro, in situ, and in vivo diagnosis or treatment of mammalian cells, or associated pathological conditions.

  这项发明涉及到式(I)的化合物，这些化合物可用作激酶抑制剂，更具体地用作PIM激酶抑制剂，因此可用作癌症治疗药物。该发明还涉及到包括这些化合物的组合物，更具体地是包括这些化合物的药物组合物，以及使用这些组合物的方法，无论是单独使用还是结合使用，用于治疗各种癌症和高增殖性疾病，以及使用这些化合物进行体外、体内和体内诊断或治疗哺乳动物细胞或相关病理条件的方法。
• LONG-ACTING HIV PROTEASE INHIBITOR
  申请人：Shionogi & Co., Ltd.

  公开号：US20170253607A1

  公开（公告）日：2017-09-07

  The present invention provides useful compounds for HIV protease inhibitor. A compound represented by the following formula or its pharmaceutically acceptable salt: wherein ring A is R 4 is —Y—Z, hydrogen atom, halogen, hydroxy and the like, R 5 is hydrogen atom, halogen, hydroxy and the like, R 6 is each independently halogen, hydroxy, carboxy and the like, ring A may be substituted with said R 6 at any substitutable position(s), a is an integer of 0 to 7, ring B is substituted or unsubstituted aromatic carbocyclyl, or substituted or unsubstituted aromatic heterocyclyl, ring C is substituted or unsubstituted aromatic carbocyclyl, substituted or unsubstituted non-aromatic carbocyclyl, substituted or unsubstituted aromatic heterocyclyl, or substituted or unsubstituted non-aromatic heterocyclyl, R 1 is —Y—Z, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl and the like, R 2 and R 3 are each independently —Y—Z or hydrogen atom, provided that at least one of R 1 , R 2 , R 3 and R 4 is a group represented by formula: —Y—Z, Y is a bond, or a spacer of any combination selected from the group consisting of —O—, —S—, —NR 7 —, —C(═O)—, —SO—, —SO 2 —, —NR 7 —C(═O)—, —C(═O)—NR 7 —, —NR 7 —C(═O)—NR 7 —, —O—C(═O)—NR 7 —, —NR 7 —C(═O)—O—, —SO 2 —NR 7 —, —NR 7 —SO 2 —, substituted or unsubstituted alkylene, substituted or unsubstituted alkenylene, substituted or unsubstituted alkynylene, substituted or unsubstituted aromatic carbocyclediyl, substituted or unsubstituted non-aromatic carbocyclediyl, substituted or unsubstituted aromatic heterocyclediyl and substituted or unsubstituted non-aromatic heterocyclediyl, R 7 are each independently hydrogen atom, hydroxy, carboxy and the like, and Z is substituted aromatic carbocyclyl, substituted non-aromatic carbocyclyl, substituted aromatic heterocyclyl or substituted non-aromatic heterocyclyl.
• US8435976B2
  申请人：——

  公开号：US8435976B2

  公开（公告）日：2013-05-07